Assault by drugs, medicaments and biological substances

VWXY20_ASSAU_DRUGS_MEDICAM_BIOLO_SUBST

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — X85 Cause of death: ICD-10 — X85 2 out of 7 registries used, show all original rules.	57
4. Check minimum number of events None	57
5. Include endpoints None	57
6. Filter based on genotype QC (FinnGen only)	57

Control definitions (FinnGen only)

Control exclude: VWXY20_ASSAULT

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: X85-Y09

NAME	VWXY20_ASSAU_DRUGS_MEDICAM_BIOLO_SUBST
CONTROL_EXCLUDE	VWXY20_ASSAULT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	X85
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	X85
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Assault by drugs, medicaments and biological substances based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	57	29	28
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	41.11	41.96	40.24

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
55: Matched controls
547

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

X85.9

ICD-10 Finland

Assault by drugs, medicaments and biological substances by unknown person

+∞

45.1

T74.1

ICD-10 Finland

Physical abuse

+∞

17.6

T36

ICD-10 Finland

Poisoning by systemic antibiotics

39.9

14.0

X85.0

ICD-10 Finland

Assault by drugs, medicaments and biological substances by spouse or partner

+∞

11.9

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

12.8

10.0

Y09

ICD-10 Finland

Assault by unspecified means

+∞

9.6

N05AH04

ATC

quetiapine; oral

7.1

8.6

Y07

ICD-10 Finland

Other maltreatment

+∞

8.5

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

12.9

8.1

F32.9

ICD-10 Finland

Depressive episode, unspecified

6.9

7.8

S06.0

ICD-10 Finland

Concussion

8.0

7.4

N05BA01

ATC

diazepam; systemic, rectal

6.8

6.6

N06AX11

ATC

mirtazapine; oral

4.5

6.5

108

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

+∞

6.4

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

+∞

6.4

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

17.5

6.1

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

17.5

6.1

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(1001926) Buprenorphine [Presence] in Urine by Screen method

7.72

8.11

2.9

1.1

—

(3011288) Drugs identified in Urine by Screen method

6.34

6.32

3.7

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

17.43

6.13

1.0

1.8

—

(3016879) Cocaine [Presence] in Urine

5.32

5.63

2.9

1.3

—

(3032080) INR in Blood by Coagulation assay

142

3.59

5.36

5.2

4.9

1.0

1.1

inr

—

(3000764) Benzodiazepines [Presence] in Urine

4.66

4.85

2.9

1.2

—

(3028300) Cannabinoids [Presence] in Urine

4.66

4.85

2.9

1.2

—

(3027008) Opiates [Presence] in Urine

4.66

4.85

2.9

1.2

—

(3027944) Amphetamines [Presence] in Urine

4.52

4.67

2.9

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3.31

4.30

3.8

1.8

—

(3042936) Bacteria identified in Isolate by Culture

3.88

4.30

2.0

2.9

—

(3028707) Methadone [Presence] in Urine by Screen method

7.40

4.17

3.2

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

200

2.94

3.79

5.4

3.7

—

(3023368) Bacteria identified in Blood by Culture

2.99

3.58

5.9

4.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

189

2.77

3.46

7.6

6.8

1.2

mmol/l

2.21

164

(3044640) Blood type and Crossmatch panel - Blood

124

2.81

3.46

4.0

1.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2.99

3.17

6.9

3.8

483.2

87.5

ng/l

—

(3026008) Bacteria identified in Urine by Culture

2.64

2.80

2.9

2.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3.58

2.80

2.3

3.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

4.25

2.57

2.0

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

4.83

2.56

1.4

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

112

2.39

2.37

2.1

2.2

0.4

0.2

e6/l

0.31

(3048929) Epstein Barr virus Ab [Presence] in Serum

5.02

2.33

1.2

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.67

2.30

3.6

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.77

2.20

2.2

1.8

—

(36304419) Bacteria [Presence] in Urine

117

2.26

2.12

2.1

—

(40768797) Stomach Pathology biopsy report

2.61

2.09

1.1

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

4.06

1.99

1.8

1.6

—

(40768804) Tissue Pathology biopsy report

179

2.11

1.99

2.3

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

121

2.16

1.93

2.3

1.9

—

(3019225) pH of Specimen

3.04

1.87

4.3

6.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

4.10

1.75

6.0

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2.13

1.66

2.0

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

3.81

1.65

2.4

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

3.81

1.65

2.0

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

138

1.97

1.57

2.6

1.9

84.1

100.3

pmol/l

1.09

(3015736) pH of Urine

175

1.89

1.50

4.5

2.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2.92

1.47

4.7

4.4

133.7

129.8

g/l

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3.32

1.47

1.2

1.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2.04

1.40

3.3

2.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3.12

1.39

15.8

7.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.05

1.36

1.4

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

127

1.89

1.35

2.3

2.2

8.7

11.2

e6/l

0.41

105

(3018095) Leukocytes [#/volume] in Urine

153

1.84

1.35

2.7

12.3

31.9

e6/l

0.41

114

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.26

1.31

2.0

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2.78

1.24

2.4

4.7

26.3

23.8

mmol/l

—

(3025941) Bacteria identified in Stool by Culture

2.46

1.22

2.2

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

313

1.78

1.16

5.4

3.5

—

(3012544) pH of Venous blood

2.43

1.15

4.4

3.7

—

(3033658) Prothrombin time (PT) actual/Normal

116

1.81

1.15

4.5

3.1

91.6

94.9

0.22

116

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

142

1.76

1.14

2.5

2.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

152

1.73

1.11

4.4

2.8

61.6

30.5

ng/l

0.26

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

454

2.17

1.10

13.7

9.2

95.5

90.9

ml/min/173m2

1.17

367

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

109

1.80

1.10

1.7

1.5

—

(40758558) Short blood count panel - Blood

109

1.80

1.10

8.5

7.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.08

1.08

2.2

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2.08

1.08

3.2

7.0

1.0

mmol/l

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.08

1.08

2.4

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.89

1.06

3.2

2.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

466

2.32

1.01

19.9

11.5

41.7

41.6

0.05

390

(4035726)

2.01

0.98

1.4

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

133

1.64

0.89

2.3

—

(42870588) Differential panel, method unspecified - Blood

160

1.61

0.89

10.3

5.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

179

1.59

0.87

4.3

2.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2.04

0.87

2.0

3.7

6.1

5.4

kpa

—

(3000494) Fungus identified in Specimen by Culture

1.81

0.85

2.4

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.79

0.79

1.4

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2.01

0.72

1.2

2.1

—

(3022145) Colonoscopy Study observation

1.76

0.71

1.6

1.5

—

(40761535) Cells panel - Urine sediment

1.93

0.70

2.4

2.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.68

0.68

1.7

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1.59

0.67

1.3

1.2

3.3

u/ml

—

(3019060) Gas panel - Arterial blood

1.79

0.65

13.2

7.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.70

0.65

2.3

1.9

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

168

1.40

0.50

6.9

3.6

34.3

30.8

u/l

0.42

161

(3021601) Nitrite [Presence] in Urine by Test strip

226

1.37

0.49

5.3

3.8

0.0

estimate

—

(3007164) IgA [Mass/volume] in Serum or Plasma

114

1.43

0.47

1.3

1.5

2.0

2.5

g/l

—

(3012516) Albumin [Mass/volume] in Urine

106

1.43

0.44

2.9

3.4

4.7

57.1

mg/l

—

(3035350) Ketones [Presence] in Urine by Test strip

229

1.34

0.44

4.4

2.7

0.0

estimate

—

(3009261) Glucose [Presence] in Urine by Test strip

230

1.33

0.43

4.4

2.7

0.0

estimate

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.42

0.0

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.42

0.0

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.42

0.0

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

3.2

—

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.40

0.0

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.47

0.40

1.4

2.1

—

(4010399)

1.47

0.40

1.4

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

1.52

0.37

5.3

2.8

—

0.6

—

(3029937) Albumin [Presence] in Urine by Test strip

119

1.35

0.36

6.1

2.8

0.0

estimate

—

(1761868) Lipid panel - Serum or Plasma

203

0.77

0.33

2.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

112

1.33

0.32

3.8

4.0

1.2

7.3

mg/mmol

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

400

0.79

0.30

3.1

3.3

—

(40761536) Microorganisms panel - Urine sediment

1.38

0.24

3.4

2.9

—

(3021440) Promyelocytes/100 leukocytes in Blood

1.38

0.24

6.2

2.9

—

0.2

—

(3025159) Blasts/100 leukocytes in Blood

1.35

0.24

2.8

—

0.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1.31

0.23

6.2

2.7

—

0.4

—

(3013512) EKG study

1.27

0.22

3.3

2.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

0.00

0.21

0.0

1.4

—

6.8

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.21

0.0

3.5

—

55.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.21

0.0

3.3

—

3.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.21

0.0

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

2.4

—

(3044889) 12 lead EKG panel

315

1.20

0.21

4.6

3.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.21

0.0

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

55.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.20

0.20

1.7

2.2

332.5

399.5

nmol/l

—

(3002256) Pathology report gross observation

1.20

0.20

1.0

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

491

1.37

0.16

4.8

4.0

2.9

mmol/l

0.15

470

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.17

0.16

3.7

2.4

0.8

mmol/l

—

(3000492) Spirometry study

1.07

0.10

1.2

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.05

0.09

8.4

7.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.06

0.09

2.7

2.6

10.6

14.6

umol/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.80

0.09

1.0

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

0.80

0.08

4.0

2.1

0.6

0.7

ug/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.04

0.07

1.4

1.3

—

(3003694) ABO and Rh group [Type] in Blood

129

1.11

0.06

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

120

0.90

0.05

5.5

3.2

1.3

1.5

ug/l

0.25

110

(40760892) CBC W Ordered Manual Differential panel - Blood

130

0.90

0.05

1.9

4.8

—

(3003338) MCHC [Mass/volume]

458

0.92

0.03

26.4

13.4

333.1

333.8

g/l

0.17

458

(3011397) Hemoglobin [Presence] in Urine by Test strip

1.01

0.00

7.4

2.9

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.0

2.8

—

18.1

—

(4027681)

0.00

0.0

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.0

2.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

32.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.0

1.7

—

77.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

0.0

2.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.00

0.0

3.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.0

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.7

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

0.0

2.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

0.00

0.0

2.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.0

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

6.2

—

18.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.0

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(21494755) Public health laboratory ask at order entry panel

1.00

0.00

1.1

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.0

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.0

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.0

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.0

2.1

—

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_ASSAU_DRUGS_MEDICAM_BIOLO_SUBST – Assault by drugs, medicaments and biological substances

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Assault by drugs, medicaments and biological substances

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Assault by drugs, medicaments and biological substances (VWXY20_ASSAU_DRUGS_MEDICAM_BIOLO_SUBST)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints